Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mitochondrial fitness and cancer risk

PLoS ONE(2022)10.1371/journal.pone.0273520Source: DataRank Database

Mitochondrial fitness and cancer risk is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.94)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Andrew T. Milcarek ORCID,Faiyaz Notta ORCID,Gun-Ho Jang,Julie M. Wilson ORCID,Steven Gallinger ORCID

Live enrichment

PubMed:36223343 PMC:PMC9555630 OpenAlex:https://openalex.org/W4304758004

National Cancer Institute NCI

Grant: P01 CA140043

National Cancer Institute NCI

Grant: R35 CA220446

National Cancer Institute NCI

Grant: R50 CA211199

NCI NIH HHS

Grant: P30 CA010815

National Institutes of Health

Grant: 7P01CA140043-02

Novel Molecular Therapies of Prostate Cancer

National Institutes of Health

Grant: 5R35CA220446-05

Tumor Plasticity

National Institutes of Health

Grant: 5R50CA211199-04

Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0273520&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0273520&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0273520

journalhttps://doi.org/10.1371/journal.pone.0273520

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36223343

Fields of Study

RNA modifications and cancerCancer, Hypoxia, and MetabolismMitochondrial Function and Pathology0301 basic medicine03 medical and health sciences

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsHumansInterferonsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalMitochondrial Proteins

Keywords

BiologyTranscriptomeGene signaturePhenotypeDownregulation and upregulationCancerBioinformaticsGeneDiseaseMitochondrionCancer researchGene expressionInternal medicineMedicineGenetics570ScienceCarcinomaQRMitochondrial ProteinsPancreatic NeoplasmsPancreatic DuctalAntineoplastic Combined Chemotherapy ProtocolsMedicine and Health SciencesHumansInterferonsResearch ArticleCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being